AbCellera Biologics Inc. (ABCL)

Healthcare · Biotechnology · NASDAQ

AbCellera Biologics Inc. (ABCL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.12B and a free-cash-flow yield of -8.4%. Over the most recent reported fiscal year, revenue grew 160.6%.

Market cap	$2.12B
Trailing P/E	—
FCF yield	-8.4%
Revenue growth (YoY)	+160.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ABCL data on Nama Insights →